[Sisa Today, Reporter Haewon Jeon] We go to the hospital because we are, so to speak, 'in pain.' The goal is to identify the cause of 'pain' — the body's distress signal — and receive appropriate tratamiento. Sin embargo, dolor crónico that follows like a shadow even after recovery from illness endlessly torments pacientes and plunges them into suffering.
The World Health Organization (WHO) classifies such dolor crónico not as a byproduct of illness but as a 'disease' in its own right. In other words, 'pain' is not just a symptom but a condition that requires tratamiento.
CEO Yongho Kim of RudaCure Inc. (www.rudacure.com), an assistant professor in the Department of Physiology at Gachon University College of Medicine, has dedicated himself to fundamental investigación on 'pain' that goes beyond conventional alivio del dolor concepts, stepping up to present a new paradigm for Korea's desarrollo de nuevos fármacos industria.
La empresa's diversified business areas include ▲ CRPS (Complex Regional Pain Syndrome) ▲ dolor neuropático ▲ cancer-induced pain ▲ ocular diseases (enfermedad de ojo seco, macular degeneration), and la empresa está desarrollando solutions in all these areas.